The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations

被引:57
|
作者
Kol, A [1 ]
Libby, P [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Cardiovasc Div,Vasc Med & Atherosclerosis Unit, Boston, MA 02115 USA
关键词
D O I
10.1016/S1050-1738(98)00010-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Three infectious agents have recently gained considerable interest as potential pathogens in atherosclerosis and in its clinical manifestations: herpes simplex virus, cytomegalovirus, and Chlamydia pneumoniae. Chronic and often asymptomatic infections with these agents occur widely in the general population. These pathogens may affect atherosclerosis either directly or indirectly. Direct effects on vascular wall cells might include cell lysis, transformation, lipid accumulation, proinflammatory changes, and augmentation of procoagulant activity. Indirect systemic effects may involve induction of acute-phase proteins, establishment of a prothrombotic state, hemodynamic stress caused by tachycardia, increased cardiac output, or a regional inflammatory activation in response to systemic endotoxemia and cytokinemia. The effects of microbial infection, usually in combination with other risk factors (for example, smoking, hyperlipidemia, family history), might promote atherogenesis and eventually trigger acute coronary events. (C) 1998 Elsevier Science inc.
引用
收藏
页码:191 / 199
页数:9
相关论文
共 27 条
  • [1] Mechanisms by Which Pharmacologic Agents May Contribute to Fatigue
    Zlott, Daniel A.
    Byrne, Mary
    PM&R, 2010, 2 (05) : 451 - 455
  • [2] The multiple mechanisms by which infection may contribute to atherosclerosis development and course
    Epstein, SE
    CIRCULATION RESEARCH, 2002, 90 (01) : 2 - 4
  • [3] DMSO may have motor effects on the bladder which contribute to its clinical activity
    Stevens, LA
    Chapple, CR
    Chess-Williams, R
    JOURNAL OF UROLOGY, 2003, 169 (04): : 45 - 45
  • [4] Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19
    Steardo, Luca
    Steardo, Luca, Jr.
    Zorec, Robert
    Verkhratsky, Alexei
    ACTA PHYSIOLOGICA, 2020, 229 (03)
  • [5] THE GENETIC-ASPECTS OF ATHEROSCLEROSIS AND ITS CLINICAL MANIFESTATIONS
    DAVIDENKOVA, EF
    KOLOSOVA, NN
    LIBERMAN, IS
    SHAFRAN, MG
    KLINICHESKAYA MEDITSINA, 1986, 64 (02): : 9 - 14
  • [6] Immune-mediated mechanisms in atherosclerosis: Prevention and treatment of clinical manifestations
    Niessner, A.
    Goronzy, J. J.
    Weyand, C. M.
    CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (36) : 3701 - 3710
  • [8] The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Behcet's disease
    Mumcu, G.
    Inanc, N.
    Yavuz, S.
    Direskeneli, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (04) : S27 - S33
  • [9] Serum-infrared spectroscopy is suitable for diagnosis of atherosclerosis and its clinical manifestations
    Peters, Andreas S.
    Backhaus, Juergen
    Pfuetzner, Andreas
    Raster, Matthias
    Burgard, Gunther
    Demirel, Serdar
    Boeckler, Dittmar
    Hakimi, Maani
    VIBRATIONAL SPECTROSCOPY, 2017, 92 : 20 - 26
  • [10] Clinical manifestations of infective endocarditis in relation to infectious agents: An 8-year retrospective study
    Pazdernik, Michal
    Kautzner, Josef
    Sochman, Jan
    Kettner, Jiri
    Vojacek, Jan
    Pelouch, Radek
    BIOMEDICAL PAPERS-OLOMOUC, 2016, 160 (02): : 298 - 304